Skip to content
2000
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882
file format pdf download PDF
side by side viewer icon HTML

Abstract

Background

Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrinal disorders in the reproductive age of women and is, therefore, a risk factor for Gestational Diabetes Mellitus (GDM). One of the medications used in the management of PCOS is metformin and its use has been proposed to decrease the occurrence of GDM. The purpose of this study focuses on the effects of the dose and duration of metformin treatment on the prevalence of GDM among pregnant women affected by PCOS.

Methods

A cross-sectional survey was carried out on 112 pregnant women diagnosed with PCOS in tertiary care hospitals in Karachi. Data were collected through a structured questionnaire, in which 55 patients received metformin and others did not receive metformin. Both groups were compared for the prevalence of GDM. Chi-square test was used in data analysis at a significance level of < 0. 05.

Results

GDM was found to be significantly higher in non-metformin group than metformin group (60% 40%, P=0.03). The data analysis extended this finding, which concluded that metformin use is inversely related to GDM risk (p = 0.02).

Conclusion

This study shows that metformin therapy reduces the incidence of GDM in pregnant PCOS patients and may be used to prevent GDM in such patients. Such outcomes indicate the possibility of the use of metformin as a means of preventing GDM in this group of patients.

2024 © 2024 The Author(s). Published by Bentham Science Publisher. The Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882367742250314043647
2024-01-01
2025-09-28

  • From This Site

    /content/journals/nemj/10.2174/0102506882367742250314043647
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/nemj/05/1/NEMJ-5-E02506882367742.html?itemId=/content/journals/nemj/10.2174/0102506882367742250314043647&mimeType=html&fmt=ahah

References

  1. BellverJ Rodríguez-TaberneroL RoblesA MuñozE MartínezF LanderasJ Polycystic ovary syndrome throughout a woman’s life.J. Assist Reprod Genet.2018351253910.1007/s10815‑017‑1047‑7
     [Google Scholar]
  2. MeczekalskiB NiwczykO KostrzakA Maciejewska-JeskeM BalaG SzeligaA PCOS in adolescents-ongoing riddles in diagnosis and treatment.J. Clin Med.2023123122110.3390/jcm12031221.
     [Google Scholar]
  3. NormanR.J. DewaillyD. LegroR.S. HickeyT.E. Polycystic ovary syndrome.Lancet2007370958868569710.1016/S0140‑6736(07)61345‑217720020
     [Google Scholar]
  4. RojasJ. ChávezM. OlivarL. RojasM. MorilloJ. MejíasJ. CalvoM. BermúdezV. Polycystic ovary syndrome, insulin resistance, and obesity: Navigating the pathophysiologic labyrinth.Int. J. Reprod. Med.2014201411710.1155/2014/71905025763405
     [Google Scholar]
  5. WangJ WuD GuoH Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sci.201923611694010.1016/j.lfs.2019.116940
     [Google Scholar]
  6. ZengX. XieY. LiuY. LongS. MoZ. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.Clin. Chim. Acta202050221422110.1016/j.cca.2019.11.00331733195
     [Google Scholar]
  7. PetersenMC Mechanisms of insulin action and insulin resistance.Physiol Rev.2018984213310.1152/physrev.00063
     [Google Scholar]
  8. MaciejczykM ŻebrowskaE Insulin resistance and oxidative stress in the brain: What's new?Int. J. Mol. Sci.201920487410.3390/ijms20040874.
     [Google Scholar]
  9. LeeS-H ParkS-Y ChoiCSJD Insulin resistance: From mechanisms to therapeutic strategies.Diabetes Metab J.2022461153710.4093/dmj.2021.0280.
     [Google Scholar]
  10. BjerckeS DalePO TanboT StorengR ErtzeidG ÅbyholmTJG Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome.Gynecol. Obstet. Invest.2002542949810.1159/00006771912566751
     [Google Scholar]
  11. FicaS. AlbuA. ConstantinM. DobriG.A. Insulin resistance and fertility in polycystic ovary syndrome.J. Med. Life20081441542220108521
     [Google Scholar]
  12. BarbourL.A. McCurdyC.E. HernandezT.L. KirwanJ.P. CatalanoP.M. FriedmanJ.E. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes.Diabetes Care200730Suppl. 2S112S11910.2337/dc07‑s20217596458
     [Google Scholar]
  13. BenhalimaK. Van CrombruggeP. MoysonC. VerhaegheJ. VandeginsteS. VerlaenenH. VercammenC. MaesT. DufraimontE. De BlockC. JacquemynY. MekahliF. De ClippelK. Van Den BruelA. LoccufierA. LaenenA. MinschartC. DevliegerR. MathieuC. Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance.Diabetologia201962112118212810.1007/s00125‑019‑4961‑731338546
     [Google Scholar]
  14. Szukiewicz D. Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity.Int J. Mol Sci.20232412981810.3390/ijms24129818
     [Google Scholar]
  15. McCurdyC.E. FriedmanJ.E. Mechanisms underlying insulin resistance in human pregnancy and gestational diabetes mellitus. Gestational diabetes during and after pregnancy.Springer201012513810.1007/978‑1‑84882‑120‑0_9
     [Google Scholar]
  16. ChoudhuryAA RajeswariVDJB Gestational diabetes mellitus: A metabolic and reproductive disorder.Biomed Pharmacother.202114311218310.1016/j.biopha.2021
     [Google Scholar]
  17. GicăN HuluțăI. Gestational diabetes mellitus.Type 2 Diabetes in 2024 - From Early Suspicion to Effective Management.IntechOpen202310.5772/intechopen.1002793
     [Google Scholar]
  18. NapsoT YongHE Lopez-TelloJ The role of placental hormones in mediating maternal adaptations to support pregnancy and lactation.Front Physiol.20189109110.3389/fphys.2018.01091
     [Google Scholar]
  19. RöderPV WuB LiuY HanWJE Pancreatic regulation of glucose homeostasis.Exp. Mol. Med.2016483e21910.1038/emm.2016.6.
     [Google Scholar]
  20. BlumA.K. Insulin use in pregnancy: An update.Diabetes Spectr.2016292929710.2337/diaspect.29.2.9227182178
     [Google Scholar]
  21. PalaniS. JosephN. TegeneY. ZachariaA. MarewT. Gestational diabetes: A review.JGTPS20145216731683
     [Google Scholar]
  22. LaneDEJO Polycystic ovary syndrome and its differential diagnosis.Obstet. Gynecol. Surv.2006612125
     [Google Scholar]
  23. ZhangZ. MeiL. LiL. XiaoJ. WuX. YuanY. Maternal and neonatal outcomes of twin pregnancies complicated by gestational diabetes mellitus.Endocrine202384238839810.1007/s12020‑023‑03588‑037946069
     [Google Scholar]
  24. Markowicz-PiaseckaM. SikoraJ. SzydłowskaA. SkupieńA. Mikiciuk-OlasikE. HuttunenK.M. Metformin: A future therapy for neurodegenerative diseases : Theme: Drug discovery, development and delivery in alzheimer's disease guest editor: Davide Brambilla. Pharm Res.201734122614262710.1007/s11095‑017‑2199‑y
     [Google Scholar]
  25. GhandiS. AflatoonianA. TabibnejadN. MoghaddamM.H.S. The effects of metformin or orlistat on obese women with polycystic ovary syndrome: A prospective randomized open-label study.J. Assist. Reprod. Genet.201128759159610.1007/s10815‑011‑9564‑221484319
     [Google Scholar]
  26. VelazquezE.M. MendozaS. HamerT. SosaF. GlueckC.J. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.Metabolism199443564765410.1016/0026‑0495(94)90209‑78177055
     [Google Scholar]
  27. ZhaoJ. LiuX. ZhangW. The effect of metformin therapy for preventing gestational diabetes mellitus in women with polycystic ovary syndrome: A meta-analysis.Exp. Clin. Endocrinol. Diabetes2020128319920510.1055/a‑0603‑339429890554
     [Google Scholar]
  28. JabeenA. YaminiV. Rahman AmberinaA. Dinesh EshwarM. VadakedathS. BegumG.S. KandiV. Polycystic ovarian syndrome: Prevalence, predisposing factors, and awareness among adolescent and young girls of South India.Cureus2022148e2794310.7759/cureus.2794336120281
     [Google Scholar]
  29. YanQ. QiuD. LiuX. XingQ. LiuR. HuY. The incidence of gestational diabetes mellitus among women with polycystic ovary syndrome: A meta-analysis of longitudinal studies.BMC Pregnancy. Childbirth.202222137010.1186/s12884‑022‑04690‑335488240
     [Google Scholar]
  30. Bidhendi YarandiR. Behboudi-GandevaniS. AmiriM. Ramezani TehraniF. Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: A systemic review, meta-analysis and meta-regression.Diabetol. Metab. Syndr.20191115810.1186/s13098‑019‑0453‑731367235
     [Google Scholar]
  31. PlowsJ.F. StanleyJ.L. BakerP.N. ReynoldsC.M. VickersM.H. The pathophysiology of gestational diabetes mellitus.Int. J. Mol. Sci.20181911334210.3390/ijms1911334230373146
     [Google Scholar]
  32. AinuddinJ.A. KaziS. AftabS. KamranA. PakistanS. Metformin for preventing gestational diabetes in women with polycystic ovarian syndrome.J. Coll. Physicians. Surg.201525423724125899185
     [Google Scholar]
  33. BoomsmaC.M. EijkemansM.J.C. HughesE.G. VisserG.H.A. FauserB.C.J.M. MacklonN.S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.Hum. Reprod. Update200612667368310.1093/humupd/dml03616891296
     [Google Scholar]
  34. GinodP. DahanM.H. Association between obesity in women, polycystic ovary syndrome and adverse obstetric outcome.Obesity: Clinical, Surgical and Practical guide.Springer2024819710.1007/978‑3‑031‑62491‑9_6
     [Google Scholar]
  35. LordJ.M. FlightI.H. NormanR.J. Metformin in polycystic ovary syndrome: Systematic review and meta-analysis.BMJ2003327742195195310.1136/bmj.327.7421.95114576245
     [Google Scholar]
  36. Diamanti-KandarakisE Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications.Endocr Rev.201233698110.1210/er.2011‑1034.
     [Google Scholar]
  37. ScannellN. VillaniA. MoranL. MantziorisE. The potential role of the mediterranean diet for the treatment and management of polycystic ovary syndrome: A review of the pathophysiological mechanisms and clinical evidence.Proc. Nutr. Soc.202411210.1017/S0029665124007584
     [Google Scholar]
  38. NagandlaK. BanerjeeI. IsmailN.B.H.M. Adipocytokines in polycystic ovary syndrome (PCOS): A systematic review and meta-analysis.AIMS Med. Sci.202310217819510.3934/medsci.2023016
     [Google Scholar]
  39. JanssenOE MehlmauerN HahnS ÖffnerAH High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome.Eur J. Endocrinol. 2004150336310.1530/eje.0.1500363.
     [Google Scholar]
  40. TanX LiS ChangY Effect of metformin treatment during pregnancy on women with PCOS: A systematic review and meta-analysis.Clin. Invest. Med.2016394E12010.25011/cim.v39i4.27091
     [Google Scholar]
  41. ŁakomaA. ChoińskiM. MarzecW.Z. Gestational Diabetes Mellitus: Prevalence.Manag. Prevent.20242154076
     [Google Scholar]
  42. AnastasiouO.E. CanbayA. FuhrerD. Reger-TanS. Metabolic and androgen profile in underweight women with polycystic ovary syndrome.Arch. Gynecol. Obstet.2017296236337110.1007/s00404‑017‑4422‑928608050
     [Google Scholar]
  43. RaperportC. ChronopoulouE. HomburgR. Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome.Expert Rev. Endocrinol. Metab.2021162374710.1080/17446651.2021.188936633634727
     [Google Scholar]
  44. Fux OttaC. WiorM. IraciG.S. KaplanR. TorresD. GaidoM.I. WyseE.P. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial.Gynecol. Endocrinol.201026317317810.3109/0951359090321558120148739
     [Google Scholar]
/content/journals/nemj/10.2174/0102506882367742250314043647
Loading
Prevalence of Gestational Diabetes in Metformin-Treated and Non-Treated PCOS Women: A Comparative Analysis
NEW Emirates Medical J 5, E02506882367742 (2024); https://doi.org/10.2174/0102506882367742250314043647
/content/journals/nemj/10.2174/0102506882367742250314043647
/content/journals/nemj/10.2174/0102506882367742250314043647
Loading

Data & Media loading...

Supplements

Supplementary material is available on the Publisher’s website.

file format download Download

  • Article Type:     Research Article
Keyword(s): Gestational diabetes mellitus (GDM); Metformin; Polycystic ovarian syndrome (PCOS); Pregnant women

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test